Search results for " thyroid"

showing 10 items of 226 documents

Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study

2019

Background: Graves' disease is one of the most common autoimmune conditions, but treatment remains imperfect. This study explores the first-in-human use of antigen-specific immunotherapy with a combination of two thyrotropin receptor (TSHR) peptides (termed ATX-GD-59) in Graves' hyperthyroidism. Methods: Twelve participants (11 female) with previously untreated mild to moderate Graves' hyperthyroidism were enrolled in a Phase I open label trial to receive 10 doses of ATX-GD-59 administered intradermally over an 18-week period. Adverse events, tolerability, changes in serum free thyroid hormones, and TSHR autoantibodies were measured. Results: Ten subjects received all 10 doses of ATX-GD-59,…

AdultMalemedicine.medical_specialtyendocrine systemendocrine system diseasesInjections Intradermalthyroid stimulating hormone receptorEndocrinology Diabetes and Metabolismmedicine.medical_treatmentGraves' diseasedesensitization030209 endocrinology & metabolismDiseaseImmunology Autoimmunity and Graves’ OphthalmopathyimmunomodulationThyrotropin receptor03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicinemedicineHumansAdverse effectDesensitization (medicine)business.industryAutoantibodypeptide immunotherapyReceptors ThyrotropinImmunotherapyMiddle Agedmedicine.diseaseGraves' diseaseGraves Disease3. Good healthInjection Site ReactionThyroxineEndocrinologyTreatment OutcomeTolerabilityDesensitization Immunologic030220 oncology & carcinogenesisTriiodothyronineFemaleautoimmune thyroid diseasebusinessPeptidesImmunoglobulins Thyroid-StimulatingThyroid
researchProduct

A gelatin-thrombin matrix topical hemostatic agent (Floseal) in combination with harmonic scalpel is effective in patients undergoing total thyroidec…

2016

BACKGROUND: Hemostasis during thyroidectomy is essential; however, the safest, most efficient, and most cost-effective way to achieve this is unclear. This randomized, multicenter, single-blind, prospective study evaluated the efficacy and safety of using different hemostatic approaches in patients undergoing total thyroidectomy. METHODS: Patients aged ≥18 to 70 years were randomized to Floseal + a harmonic scalpel (HS), Floseal alone, HS alone, or standard total thyroidectomy. Primary endpoint was 24-hour drain output. Secondary endpoints included surgery duration and complications. RESULTS: Two hundred and six patients were randomized to Floseal + HS (n = 52), Floseal alone (n = 54), HS a…

AdultMalemedicine.medical_specialtyfood.ingredientmedicine.medical_treatmenthemostatic agent030230 surgeryGelatinHemostaticslaw.invention03 medical and health sciencesHemostatic0302 clinical medicinefoodThrombinRandomized controlled triallawHarmonic scalpelHumansMedicineProspective StudiesProspective cohort studyFloseal; gelatin-thrombin matrix; harmonic scalpel; hemostatic agent; total thyroidectomy;Hemostatic Agentbusiness.industryharmonic scalpelThrombinThyroidectomygelatin-thrombin matrixMiddle AgedSurgical InstrumentsGelatin Sponge AbsorbableSurgerytotal thyroidectomyProspective StudieTreatment Outcome030220 oncology & carcinogenesisHemostasisAnesthesiaThyroidectomyGelatinFemaleSurgerybusinessFlosealHumanmedicine.drug
researchProduct

Ciclosporin and thyroid-stimulating immunoglobulins in endocrine orbitopathy.

1989

The study investigated whether ciclosporin (C) affected the thyroid-stimulating immunoglobulins (TSI) in serum of patients with endocrine orbitopathy (EO). The effect of C was compared with that of prednisone (P). Fifteen patients with EO classes III-V received C (n = 7) or P (n = 8). In addition to the immunosuppressants, five patients with Graves' disease in each group received methimazole (MMI). The stimulation of the cAMP levels in the medium of thyrocyte cultures was determined as a parameter of TSI. The TSI levels were markedly lowered in both groups during and after therapy. C group: before therapy 6.2 pmol/ml +/- 1.63 (100%, mean +/- SEM), during treatment 4.6 pmol/ml +/- 2.28 (74%)…

AdultMalemedicine.medical_specialtymedicine.drug_classGraves' diseasemedicine.medical_treatmentThyroid GlandCyclosporinsPrednisoneInternal medicinemedicineCyclic AMPExophthalmosHumansAgedChemotherapyTriiodothyronineMethimazolebusiness.industryThyroidGeneral MedicineMiddle Agedmedicine.diseaseCiclosporinGraves DiseaseTiterEndocrinologymedicine.anatomical_structureImmunoglobulin GCorticosteroidPrednisoneTriiodothyronineFemalebusinessmedicine.drugImmunoglobulins Thyroid-StimulatingResearch in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie
researchProduct

The prevalence of post-thyroidectomy chronic asthenia: a prospective cohort study

2017

Chronic asthenia (CA) is complained by some patients that have undergone thyroid surgery. We evaluate its impact in patients undergoing unilateral or bilateral thyroidectomy, the trend during a 1-year follow-up, and the possible risk factors. A prospective, cohort study was carried out on 263 patients scheduled for thyroidectomy from 2012 and 2014. Exclusion criteria were as follows: Graves’ disease, malignancies requiring radioiodine therapy, post-surgical hypoparathyroidism, laryngeal nerve palsy, abnormal pre- and post-operative thyroid hormone levels, and BMI outside the normal range. Demographics; smoking and alcoholism addiction; cardiac, pulmonary, renal, and hepatic failure; diabete…

AdultMalemedicine.medical_specialtymedicine.medical_treatment030209 endocrinology & metabolismCohort Studies03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsInternal medicineHemithyroidectomyPrevalencemedicineHumansRisk factorTotal thyroidectomyProspective cohort studyFatigueDepression (differential diagnoses)AgedChronic astheniabusiness.industryThyroidectomyMiddle Agedmedicine.diseaseThyroid DiseasesSurgeryCardiac surgerySettore MED/18 - Chirurgia GeneraleTreatment OutcomeHypoparathyroidismAsthenia030220 oncology & carcinogenesisChronic DiseaseThyroidectomyFemaleSurgerybusinessAbdominal surgeryCohort studyChronic asthenia; Fatigue; Hemithyroidectomy; Total thyroidectomy; Surgery
researchProduct

Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy

2017

Abstract Background: To assess the long-term prognostic value of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in patients with differentiated thyroid carcinoma (DTC) undergoing empiric radioiodine (RAI) therapy due to raising values of thyroglobulin (Tg). Methods: Forty-nine patients with histological diagnosis of DTC (31 with papillary and 18 with follicular carcinoma) follow-up for a mean period of 7.9 ± 5 years after empiric RAI therapy were retrospectively analyzed. Results: FDG-PET/CT was negative in 15 (30.6%) patients and positive in 34 (69.4%), whereas postradioiodine therapy whole body scan (t-WBS) was negative in 16 (32.7%) and positive in…

AdultMalemedicine.medical_specialtymedicine.medical_treatment18F-FDG-PET/CTchemistry.chemical_elementIodinethyroglobulinDiagnostic Accuracy StudyDisease-Free Survival030218 nuclear medicine & medical imagingThyroid carcinomaIodine Radioisotopes03 medical and health sciences0302 clinical medicineFluorodeoxyglucose F18Positron Emission Tomography Computed TomographymedicineHumansThyroid NeoplasmsThyroid cancerdifferentiated thyroid carcinomaAgedRetrospective Studies18F-FDG-PET/CT differentiated thyroid carcinoma empiric therapy prognosis thyroglobulin4300medicine.diagnostic_testbusiness.industryRetrospective cohort studyempiric therapyGeneral MedicineMiddle Agedmedicine.diseasechemistryPositron emission tomography030220 oncology & carcinogenesisF-18-FDG-PETHistopathologyThyroglobulinFemaleRadiologyprognosisRadiopharmaceuticalsNuclear medicinebusinessEmpiric therapyCTResearch Article
researchProduct

European perspective on the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroi…

2018

The American Thyroid Association (ATA) management guidelines for patients with thyroid nodules and differentiated thyroid cancer (DTC) are highly influential practice recommendations. The latest revision appeared in 2015 ("ATA 2015"). These guidelines were developed predominantly by North American experts. European experts frequently have different perspectives, given epidemiological, technological/methodological, practice organization, and medicolegal differences between the respective regions.Divergent viewpoints were the focus of an invited symposium organized by the European Association of Nuclear Medicine involving 17 European thyroidologists, four ATA Guidelines Taskforce members, and…

AdultThyroid nodulesendocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismMedizinThyroid Gland030209 endocrinology & metabolismrisk stratificationHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciences0302 clinical medicineEndocrinologyAll institutes and research themes of the Radboud University Medical CenterInternal medicineHumansMedicineThyroid NeoplasmsThyroid NoduleguidelinesDisease management (health)differentiated thyroid cancer (DTC)Thyroid cancerAdult patientsbusiness.industrythyroid nodulesPerspective (graphical)Thyroidmedicine.diseaseUnited Statesdifferentiated thyroid cancer (DTC); disease management; guidelines; pathology; risk stratification; thyroid nodules; Endocrinology Diabetes and Metabolism; EndocrinologyEuropeDiabetes and Metabolismmedicine.anatomical_structuredisease management030220 oncology & carcinogenesisPractice Guidelines as TopicRisk stratificationpathologybusiness
researchProduct

Fetal/Neonatal Thyrotoxicosis in a Newborn From a Hypothyroid Woman With Hashimoto Thyroiditis.

2016

Context: Fetal/neonatal thyrotoxicosis is a rare but potentially life-threatening condition. It is most commonly observed in poorly controlled Graves’ disease during pregnancy. Case Description: Here we describe the first reported case of thyrotoxicosis in a fetus/newborn from a woman with Hashimoto’s thyroiditis and levothyroxine-treated hypothyroidism. Transplacental passage of stimulating TSH-receptor antibodies, measured by a cell-based bioassay, was the underlying mechanism of fetal/neonatal thyrotoxicosis even though the mother had no history of hyperthyroidism. Conclusion: Diagnosis and management of fetal hyperthyroidism can be challenging. TSH receptor antibody testing should be co…

Adultendocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismGraves' diseaseClinical Biochemistry030209 endocrinology & metabolismContext (language use)DiseaseHashimoto DiseaseBiochemistryThyroiditisInfant Newborn Diseases03 medical and health sciences0302 clinical medicineEndocrinologyHypothyroidismPregnancyInternal medicinemedicineHumansHashimoto DiseaseFetusPregnancybusiness.industryBiochemistry (medical)Infant NewbornTransplacentalmedicine.diseasePrognosisPregnancy ComplicationsFetal DiseasesEndocrinologyThyrotoxicosis030220 oncology & carcinogenesisFemalebusinesshormones hormone substitutes and hormone antagonistsImmunoglobulins Thyroid-StimulatingThe Journal of clinical endocrinology and metabolism
researchProduct

Subclinical hypothyroidism resulting from autoimmune thyroiditis in female patients with endogenous depression.

1994

Thyroid function and presence of thyroid autoantibodies were assessed in a group of 75 consecutive female patients with mood disturbances and in a group of 38 healthy women of similar age recruited as controls. Nine patients suffered from major (endogenous) depression and 66 from minor (neurotic) depression. The individual patients had normal values of circulating thyroid hormones. Nevertheless, endogenously depressed patients had total serum triiodothyronine (M±SE=1.49±0.09 nmol/l) and both total (83.9±4.3 nmol/l) and free serum thyroxine (13.9±1.1 pmol/l) lower than in the group of minor depressed and in the group of controls (p<0.01, in both comparison). The median value of serum thyrotr…

Adultendocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentThyrotropinThyroid function testsThyroglobulinThyroiditisAutoimmune thyroiditisEndocrinologyHypothyroidismThyroid peroxidaseInternal medicinemedicineHumansAgedAutoantibodiesDepressive DisorderTriiodothyroninebiologymedicine.diagnostic_testbusiness.industryThyroiditis AutoimmuneMiddle Agedmedicine.diseaseAnti-thyroid autoantibodiesEndocrinologybiology.proteinThyroglobulinFemaleThyroid functionbusinessJournal of endocrinological investigation
researchProduct

Possible link between Hashimoto's thyroiditis and oral lichen planus: a novel association found

2013

Objectives: Hashimoto's thyroiditis as well as lichen planus has been associated to a number of disorders, generally of auto-immune origin. A novel possible association between oral lichen planus (OLP) and Hashimoto's thyroiditis (HT) is here proposed on the basis of a cross-sectional survey. Materials and methods: One hundred and five unrelated OLP patients were considered. Diagnosis of HT was based on positive serum anti-TPO, anti-Tg, TSH levels and the typical ultrasound pattern of the thyroid gland. Results: In the present survey, the prevalence of HT in the OLP group was 14. 3 % whereas the prevalence of HT-related hypothyroidism in the general population was reported to be equal to 1 …

Adultendocrine systemmedicine.medical_specialtyendocrine system diseasesPopulationThyrotropinAutoimmunityHashimoto Diseasemedicine.disease_causeAutoantigensIodide PeroxidaseGastroenterologyAsymptomaticThyroiditisAutoimmunityHashimoto's thyroiditistomatognathic systemSettore MED/28 - Malattie OdontostomatologicheIron-Binding ProteinsInternal medicinePrevalencemedicineHumansThyroid NoduleOral mucosaeducationGeneral DentistryAutoantibodieseducation.field_of_studybusiness.industryThyroidMiddle AgedCirculating thyroid antibodiesmedicine.diseaseAnti-thyroid autoantibodiesThyroxinestomatognathic diseasesCross-Sectional Studiesmedicine.anatomical_structureItalyOral lichen planuHashimoto's thyroiditis; Oral lichen planus; Autoimmunity; Circulating thyroid antibodiesTriiodothyronineFemaleOral lichen planusmedicine.symptombusinessLichen Planus OralClinical Oral Investigations
researchProduct

Swallowing disorders after thyroidectomy: What we know and where we are. A systematic review.

2017

Abstract Introduction Dysphagia and hoarseness are possible complications that can be observed in patients undergoing thyroidectomy or other neck surgery procedures. These complaints are usually related to superior and inferior laryngeal nerves dysfunction, but these can appear even after uncomplicated surgical procedure. Methods We reviewed the current literature available on MEDLINE database, concerning the swallowing disorders appearing after the thyroidectomy. The articles included in the review reported pathophysiology and diagnostic concerns. Results Twenty articles were selected for inclusion in the review. Depends on the possible causes of the difficulty swallowing (related to nerve…

Adultmedicine.medical_specialtymedicine.medical_treatmentLaryngoscopyPh monitoring03 medical and health sciences0302 clinical medicinePostoperative ComplicationsSwallowingLaryngeal nervemedicineRecurrent Laryngeal Nerve InjurieHumansDeglutition DisorderGastroesophageal reflux; Laryngeal nerves; Swallowing; ThyroidectomyGastroesophageal reflux; Laryngeal nerves; Swallowing; Thyroidectomy; Surgerymedicine.diagnostic_testbusiness.industrySwallowing DisordersGold standardThyroidectomyGeneral MedicineSwallowingMiddle AgedDysphagiaEndoscopySurgerySettore MED/18 - Chirurgia GeneraleGastroesophageal reflux030220 oncology & carcinogenesisRecurrent Laryngeal Nerve InjuriesThyroidectomy030211 gastroenterology & hepatologySurgeryPostoperative Complicationmedicine.symptombusinessDeglutition DisordersHumanInternational journal of surgery (London, England)
researchProduct